design_sans_titre_1_.jpg

Affluent Medical signs agreements for mitral valve technologies with €15M upfront payment

July 12, 2024

Affluent Medical a French clinical-stage medical technology company specializing in the international development and industrialization of innovative medical devices, today announced that it has signed several agreements with Edwards Lifesciences related to Affluent’s structural heart products (adjustable mitral annulus Kalios™) and technologies (mitral valve technology). Under the terms of these agreements, Affluent will receive EUR 15 million upfront as a cash payment.